<DOC>
	<DOCNO>NCT01618773</DOCNO>
	<brief_summary>This observational study design ass long-term efficacy safety Epiduo ( alone combination drug ) daily clinical practice condition patient moderate severe inflammatory acne . In addition , effect Epiduo quality life patient adherence assess marketed condition .</brief_summary>
	<brief_title>Long-term Study Epiduo Patients With Moderate Severe Acne</brief_title>
	<detailed_description>This observational study design ass long-term efficacy safety Epiduo daily clinical practice condition . The study include patient age moderate severe inflammatory acne , take Epiduo alone combination drug . In addition , effect Epiduo alone combination drug quality life patient adherence assess marketed condition . The observational study design multicentre study , cover part Germany . Participating investigator dermatologist adequate patient pool acne patient . The observation time per patient 9 month . An interim final examination subsequent documentation designate perform 3 9 month start treatment , respectively .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>The patient diagnose moderate severe inflammatory acne ( Leeds Grade 412 ) Topical therapy acne Epiduo indicate , decision treat patient Epiduo make independently study Use Epiduo within 3 month prior inclusion Pregnancy breastfeed Acne inversa Acne preferential manifestation microcysts , macrocysts macrocomedones Hypersensitivity drug ingredient If applicable , restriction outline SPC Epiduo</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>acne</keyword>
	<keyword>Epiduo</keyword>
	<keyword>adapalene/ benzoyl peroxide</keyword>
</DOC>